Canadian Pharmaceuticals & Biotech Big Green Snowflakes

BioSyent

Market Cap: CA$112.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Medexus Pharmaceuticals

Market Cap: CA$76.8m

Operates as a pharmaceutical company in Canada and the United States.

Green Thumb Industries

Market Cap: CA$1.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Decibel Cannabis

Market Cap: CA$34.6m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Planet 13 Holdings

Market Cap: CA$110.6m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Covalon Technologies

Market Cap: CA$64.4m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Aurora Cannabis

Market Cap: CA$322.7m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Delivra Health Brands

Market Cap: CA$5.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Knight Therapeutics

Market Cap: CA$574.3m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Captor Capital

Market Cap: CA$2.0m

Engages in the retail sale of cannabis products in the United States.

1CM

Market Cap: CA$38.9m

Operates as a multi-jurisdictional cannabis company in Canada.

Oncolytics Biotech

Market Cap: CA$71.9m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

TerrAscend

Market Cap: CA$127.9m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Rubicon Organics

Market Cap: CA$27.8m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada.

Satellos Bioscience

Market Cap: CA$109.4m

A biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia.

Microbix Biosystems

Market Cap: CA$50.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Rize Oncology

Market Cap: CA$4.5m

A pharmaceutical company, develops oncology therapies for the treatment of soft tissue sarcoma.

XORTX Therapeutics

Market Cap: CA$4.9m

A late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection.

Crescita Therapeutics

Market Cap: CA$11.0m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Curaleaf Holdings

Market Cap: CA$839.6m

Produces and distributes cannabis products in the United States and internationally.

Medicenna Therapeutics

Market Cap: CA$74.3m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Rakovina Therapeutics

Market Cap: CA$7.7m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Cronos Group

Market Cap: CA$906.6m

Operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

COSCIENS Biopharma

Market Cap: CA$12.6m

A specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally.

BriaCell Therapeutics

Market Cap: CA$22.3m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Bright Minds Biosciences

Market Cap: CA$312.9m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Sernova Biotherapeutics

Market Cap: CA$55.8m

Operates as a clinical-stage biotechnology company in Canada.

Digicann Ventures

Market Cap: CA$441.1k

Operates in the cannabis industry.

Organigram Global

Market Cap: CA$192.6m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

High Tide

Market Cap: CA$228.2m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Restart Life Sciences

Market Cap: CA$1.7m

Through its subsidiaries, operates as a biotechnology company worldwide.

Cipher Pharmaceuticals

Market Cap: CA$293.5m

Operates as a specialty pharmaceutical company in Canada.

Innovotech

Market Cap: CA$6.0m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Telo Genomics

Market Cap: CA$10.0m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

Biocure Technology

Market Cap: CA$3.8m

Together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.

Verano Holdings

Market Cap: CA$251.3m

Operates as a vertically integrated multi-state cannabis operator in the United States.